Medical/Pharmaceuticals

Danone to support Government's fight against COVID-19 in Malaysia

KUALA LUMPUR, Malaysia, April 1, 2020 /PRNewswire/ -- To overcome COVID-19 together as one, Dumex' parent company Danone has committed to supporting the Malaysian government in managing the health crisis, in line with its "One Planet . One Health" global vision. As in many countries in ASEAN and i...

2020-04-01 12:00 4100

Data on NASH Candidate ASC40 to be Presented at EASL ILC 2020

HANGZHOU and SHAOXING, China, April 1, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that its partner Sagimet Biosciences (formerly 3-V Biosciences, Inc), will present clinical and preclinical data on non-alcoholic steatohepatitis (NASH) drug candidate TVB-2640 (Ascl...

2020-04-01 08:30 2901

Thermo Fisher Scientific Launches New AcroMetrix Coronavirus 2019 (COVID-19) RNA Control (RUO)

To monitor and validate COVID-19 molecular diagnostic tests FREMONT, Calif., April 1, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific AcroMetrix Coronavirus 2019 (COVID-19) RNA Control, its latest quali...

2020-04-01 04:04 1348

IONpath and Bristol Myers Squibb Jointly Author New Laboratory Investigation Article Exploring the Complexities of the Tumor Microenvironment

MENLO PARK, California, April 1, 2020 /PRNewswire/ -- IONpath, Inc. today announces that they have jointly authored with Bristol Myers Squibb an article entitledMultiplexed Ion Beam Imaging (MIBI) for Characterization of the Tumor Microenvironment Across Tumor Types for the Nature journal Laborat...

2020-04-01 02:33 2801

Saxenda® Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity

BAGSVÆRD, Denmark, April 1, 2020 /PRNewswire/ -- Novo Nordisk today announced that theNew England Journal of Medicine published results of a phase 3 trial evaluating the investigational use of Saxenda® (liraglutide 3.0 mg) in adolescents (aged 12–<18) with obesity.1 The study was accepted for pr...

2020-04-01 00:00 1081

Cyient to Support Manufacturing of Critical Medical Technology in the Fight Against COVID-19

- Cyient's Mysore facility to support manufacturing of COVID-19 diagnosis units and X-ray system assemblies HYDERABAD, India, March 31, 2020 /PRNewswire/ -- Cyient, a global engineering and technology solutions company, today announced that it has received clearance for its Mysore facility to ru...

2020-03-31 23:10 1877

YITU's AI Powered Intelligent Evaluation System of Chest CT for COVID-19 Officially Launched and Put Into Use

SHANGHAI, March 31, 2020 /PRNewswire/ -- The Intelligent Evaluation System of Chest CT for COVID-19, developed by YITU under the guidance of Shanghai Public Health Clinical Center, was officially launched and was put into the first-line battle against COVID-19 pandemic on Jan. 28. It is the first...

2020-03-31 20:32 2053

Yiling Pharmacy Lianhua Qingwen has been approved by the Ministry of Health of Thailand

SHIJIAZHUANG, China, March 31, 2020 /PRNewswire/ -- On March 31, Shijiazhuang Yiling Pharmaceutical Co., Ltd released a notice that they had received the approval of the modern herbal medicine registration issued by the ministry of health ofThailand. Lianhua Qingwen Capsule is recognized as in li...

2020-03-31 18:15 3043

Hong Kong Hypnotherapist Launches Global App for De-stressing in the Time of Coronavirus

HONG KONG, March 31, 2020 /PRNewswire/ -- As cases of COVID-19 increase around the world, leadingHong Kong hypnotherapist Christine Deschemin of the Renewed Edge Hypnotherapy Center, has developed a new hypnosis app that strives to support those struggling with stress and anxiety to relax, remain...

2020-03-31 15:30 2115

Clarity appoints Dr Gillies O'Bryan-Tear to Chair Newly Formed Global Clinical Development Group

SYDNEY, March 31, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Dr Gillies O'Bryan-Tear will be chairing Clarity's newly formed Global Clinical Development group. Dr O'Bryan-Tear joined the pha...

2020-03-31 12:10 1372

Singapore-headquartered Telehealth Start-up Doctor Anywhere Closes US$27 Million Series B Financing Led by Square Peg, EDBI and IHH Healthcare

SINGAPORE, March 31, 2020 /PRNewswire/ -- Doctor Anywhere , a regional tech-led healthcare company headquartered inSingapore, announced today that it has secured a US$27 million Series B financing round led by Square Peg -- the largest venture capital fund inAustrali...

2020-03-31 10:00 3873

Innovent Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Progress

SUZHOU, China, March 30, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune, metabolic and oth...

2020-03-31 00:08 4143

INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-associated Vulvar Dysplasia

PLYMOUTH MEETING, Pennsylvania, March 30, 2020 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (NASDAQ: INO) today reported interim results from an open-label Phase 2 trial designed to evaluate the safety and efficacy of VGX-3100 in women with vulvar dysplasia, also known as high grade squamous int...

2020-03-30 21:00 2858

OssDsign Receives Regulatory Approval and Prepares for Launch in Japan

STOCKHOLM, March 30, 2020 /PRNewswire/ -- OssDsign AB (publ) today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval of OssDsign Cranial PSI for the Japanese market. OssDsign plans to launch OssDsign Cranial PSI inJapan together with a national dis...

2020-03-30 20:42 1664

RavenPack Launches Free Coronavirus News Monitor to Help Data-driven Professionals Face the Challenging New Market Conditions

NEW YORK, March 30, 2020 /PRNewswire/ -- In response to the coronavirus pandemic, RavenPack, a leading provider of big data analytics, has launched a live and interactive website to help navigate the oceans of information currently available on the novel coronavirus and its impact on world affair...

2020-03-30 20:00 1882

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use

Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest bySeptember 2020 Johnson & Johnson Will Establish New U.S. Vaccine Manufacturing Capab...

2020-03-30 19:32 4554

SHL Medical acquires Weibel CDS

ZUG, Switzerland, March 30, 2020 /PRNewswire/ -- SHL Medical, a pioneer and technology frontrunner in the self-injection industry, announced its acquisition of Weibel CDS, a medical technology company offering products and solutions for drug delivery and novel packaging. Weibel was established i...

2020-03-30 14:00 1952

CSPC Pharmaceutical Announces 2019 Annual Results

Profit Attributable To Shareholders Increased 20.6% to RMB3,714 Million Innovative Drug Business Continued to Deliver Strong Growth New Products Launched Helped to Sustain Growth HONG KONG, March 30, 2020 /PRNewswire/ -- CSPC Pharmaceutical Group Limited  (HKEx: 01093) ("CSPC Pharmaceutical" or the...

2020-03-30 12:34 3571

Vela Diagnostics to offer manual ViroKey™ SARS-CoV-2 RT-PCR Test after completion of Emergency Use Authorization validation, targeted to be complete by early April 2020

SINGAPORE, March 30, 2020 /PRNewswire/ -- Ahead of Emergency Use Authorization (EUA) and in accordance with the U.S. Food and Drug Administration (FDA) Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency guidance document issued on March 16, 2020, Vela Diag...

2020-03-30 12:06 1449

Nano Retina Announces Preliminary Results for First-in-Human Implantation of Its NR600 Artificial Retina Device

The device is designed to restore vision to persons blinded by age-related macular degeneration and retinitis pigmentosa First two patients to receive the device in March 2020 report visual effect HERZLIYA, Israel, March 30, 2020 /PRNewswire/ -- Nano Retina Ltd., developer of the NR600, an artif...

2020-03-30 08:00 1957
1 ... 376377378379380381382 ... 397